NCT04495855View on ClinicalTrials.gov

A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants

CompletedOBSERVATIONAL
Enrollment

968

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions
Endometriosis
Interventions
DRUG

Dienogest (Visanne,BAY86_5258)

2 mg (once a day), oral, tablet.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT04495855 - A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants | Biotech Hunter | Biotech Hunter